Tianjin TEDA Biomedical Engineering Company Limited (HKG:8189)

Market Cap	322.22M -67.9%
Revenue (ttm)	581.96M +35.7%
Net Income	-101.07M
EPS	-0.05
Shares Out	2.13B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,150,000
Open	0.1300
Previous Close	0.1220
Day's Range	0.1300 - 0.1760
52-Week Range	0.1140 - 0.5400
Beta	-0.49
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About HKG:8189

Tianjin TEDA Biomedical Engineering Company Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of biological compound fertilizer products in the People’s Republic of China. It operates through two segments: Fertiliser Products, and Elderly Care and Health Care Services. The company’s biological compound fertilizer products include active fertilizer, mixture with nitrogen, phosphorus, and potassium with various formulas that are used for the facilitation of balanced growth of grains, fruits, and ...

• Industry: Agricultural Inputs
• Sector: Materials
• Founded: 2000
• Employees: 273
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 8189

Financial Performance

In 2025, HKG:8189's revenue was 522.97 million, an increase of 35.67% compared to the previous year's 385.48 million. Losses were -90.82 million, 226.7% more than in 2024.

Financial numbers in CNY